Related Experiment Video

Updated: Jul 6, 2026

The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble
06:50

The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble

Published on: June 5, 2021

Rear-view mirrors and crystal balls: a brief reflection on drug discovery

John S Lazo

    Molecular Interventions
    |April 12, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
    08:35

    Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

    Published on: May 29, 2021

    High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
    06:19

    High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

    Published on: March 10, 2023

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble
    06:50

    The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble

    Published on: June 5, 2021

    Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
    08:35

    Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

    Published on: May 29, 2021

    High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
    06:19

    High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

    Published on: March 10, 2023

    Related Concept Videos

    Drug Discovery: Overview01:26

    Drug Discovery: Overview

    Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Targeting PTP4A3 with KVX-053 mitigates alcohol-amplified SARS-CoV-2 spike protein-induced acute lung injury.

    Frontiers in pharmacology·2026

    The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice.

    Respiratory research·2025

    KVX-053, a protein tyrosine phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 spike protein subunit 1-induced acute lung injury in mice.

    The Journal of pharmacology and experimental therapeutics·2025

    Deletion of PTP4A3 phosphatase in high-grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release.

    The Journal of pharmacology and experimental therapeutics·2025

    KVX-053, a Protein Tyrosine Phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 Spike protein subunit 1 - induced acute lung injury in mice.

    The Journal of pharmacology and experimental therapeutics·2024

    Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.

    Nature medicine·2024

    Spindle poisons and cell fate: a tale of two pathways.

    Molecular interventions·2011

    CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

    Molecular interventions·2011

    Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.

    Molecular interventions·2011

    New therapeutic approaches to combat arterial thrombosis: better drugs for old targets, novel targets, and future prospects.

    Molecular interventions·2011

    Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

    Molecular interventions·2011

    NOX isoforms and reactive oxygen species in vascular health.

    Molecular interventions·2011

    Machine Learning-Driven Bioprospecting of Cholinergic Medicinal Plants for Putative Leads Against Butyrylcholinesterase Towards Alzheimer's Care.

    Biochemistry research international·2026

    Mirror-Peptidizer: In Silico Mirror-Image Screening Enables De Novo Design of D-Peptide Binders without D-Protein Synthesis.

    Research (Washington, D.C.)·2026

    Molecular dynamics analysis of a docking-derived baicalein-PPARγ ligand-binding-domain model suggests a pocket-associated AF-2-anchor-silent ensemble.

    Frontiers in molecular biosciences·2026

    Oxadiazolone-Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II-Induced Vascular Contraction.

    ChemMedChem·2026

    The Pyrazolone Scaffold: A Privileged Motif for Molecular Hybridization in Drug Discovery.

    ChemMedChem·2026

    Prediction of Distal Mutation Effects in Enzymes via Integration of Molecular Dynamics Descriptors and Zero-Shot Model.

    Journal of chemical theory and computation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us